Announcements Board Message Board


Introducing the Medtech[y] Medical Sales Job Board

3 days ago

Medtechy Featured Jobs: Rep-Lite

4 months ago

The Medtechy Newsletter

5 months ago

Medtech[y] Medical Sales Job Board

6 months ago

FDA Grants Fast Track Designation for FARXIGA in Heart Failure

13 hours ago

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).

Enter for a Chance to Score Your Own iPhone XS Max & AirPods

6 months ago


No strings attached. Enter for a chance to win an iPhone XS Max and AirPods from the Medtechy Store.

Ending In: about 1 month

The iPhone XS Max 256GB + AirPods Giveaway

Enter for a Chance to Score Your Own iPhone XS Max & AirPods

Become a Featured Contributor to Medtechy

1 year ago

Send us an email at info@medtechy.com if you are interested in becoming a content contributor to our site.

You can also submit articles anonymously if you like. Learn more in the link below.

Intact Vascular to Announce One-Year Data from TOBA III Clinical Trial

13 hours ago

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year data from its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial will be presented during the High Impact Clinical Research session of the 31st

Have a scoop that you'd like Medtechy to cover? Let us know through our new tip line.

1 year ago

With the launch of our new homepage, we created an anonymous tip line in case you aren't comfortable sharing tips on our forums. Just follow this link and share your tip. No name or email required!

Coming soon: A way for you to share your tip and have a whistleblower attorney anonymously review your claim.

Submit an Anonymous Tip | Medtechy

Connecting the medical device and pharmaceutical industries. Join the conversation on one of our anonymous message boards for over 500 companies and hospitals.

Featured Medical Device Job

1 year ago

The above opportunity is for Springfield MA. Bachelor's degree, hospital call points (pharma/biotech is just fine) interested in implantable surgical sales. Call point is focused in women's health.

$55k base salary, first year on target earnings should be in the $130k range. Again, this is an surgical sales job so a minimum of 2 years of strong DOCUMENTED success with hospital call points is necessary for candidates to be considered.

Apply in the link.

Surgical Sales Representative at Chase MedSearch

The above opportunity is for Springfield MA.  Bachelor's degree, hospital call points (pharma/biotech is just fine) interested in implantable surgical...

Featured Job: Clinical Specialist Interventional Pain & Spine & More

2 years ago

We've had three great jobs posted to our new recruiting platform in the last 24 hours and would like to share them with our growing community. In case you are not familiar, we recently launched a recruiting platform where candidates and recruiters/employers can easily connect. Employers can post jobs (reach out for a trial) and candidates can view and apply for jobs, simplifying the recruiting process for all involved. Best of all, signup for candidates is free and it always will be.

Here is one …

Clinical Specialist / Interventional Pain & Spine / No patient contact at Chase MedSearch

Join an organization with a very BIG future! This reports to the Manager of Clinical Resources.  If you were at NANS in Las Vegas this past year...

National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

14 hours ago

​Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that the National Lipid Association (NLA) has issued a position statement recognizing the cardiovascular risk-lowering effects of icosapent ethyl based on the landmark REDUCE-IT cardiovascular outcomes study.

Celgene Announces Phase 3 QUAZAR AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

3 days ago

Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001. The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML)

Anonymously send rumors and tips to Medtechy

2 years ago

If you are interested in sharing a rumor or tip, but do not feel comfortable writing on the anonymous boards, you are welcome to anonymously email us at Medtechy Tips and we can write about the tip or share it to the corresponding company board for you. You can also send us files and we can post those files after they are reviewed.

Thank you all for helping us grow and being a platform to anonymously share tips, rumors and layoff discussions in the medical sales industry.

Follow Medtechy on LinkedIn

2 years ago

Give us a follow on LinkedIn and get notified when we post our latest articles from our medical sales blog, The Ticker.


Medtechy Company LinkedIn Page

Our most popular discussions and original articles from our medical sales blog, The Ticker

Loading...